{"title":"Human Immunodeficiency Virus: AIDS, the Current Plague","authors":"M. Oldstone","doi":"10.1093/oso/9780190056780.003.0016","DOIUrl":null,"url":null,"abstract":"This chapter explores acquired immunodeficiency syndrome (AIDS), a lethal disease cause by the human immunodeficiency virus (HIV). Of the more than 75 million people HIV has infected in the 36 years (1983–2019) since the initial case report, nearly one-half of them have died. Not only the victims of this infection but also their families, communities, countries, and even continents endured years of suffering as AIDS proceeded on its long course of physical destruction. Today, however, the enormous advance in antivirus drug therapy has dramatically reduced the death rate and altered the portrait of this disease from an acute lethal disease to a chronic persistent infection. In 2019, the combination antiretroviral therapy has enabled those infected to survive at roughly the same rate as the general non-infected population. However, this increased longevity includes an upsurge in the former group’s medical problems caused by the side effects of antiretroviral therapy. Despite an outlay of $1 billion per year for AIDS research, no vaccine is on the horizon for preventing this medical catastrophe.","PeriodicalId":403735,"journal":{"name":"Viruses, Plagues, and History","volume":"96 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Viruses, Plagues, and History","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/oso/9780190056780.003.0016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This chapter explores acquired immunodeficiency syndrome (AIDS), a lethal disease cause by the human immunodeficiency virus (HIV). Of the more than 75 million people HIV has infected in the 36 years (1983–2019) since the initial case report, nearly one-half of them have died. Not only the victims of this infection but also their families, communities, countries, and even continents endured years of suffering as AIDS proceeded on its long course of physical destruction. Today, however, the enormous advance in antivirus drug therapy has dramatically reduced the death rate and altered the portrait of this disease from an acute lethal disease to a chronic persistent infection. In 2019, the combination antiretroviral therapy has enabled those infected to survive at roughly the same rate as the general non-infected population. However, this increased longevity includes an upsurge in the former group’s medical problems caused by the side effects of antiretroviral therapy. Despite an outlay of $1 billion per year for AIDS research, no vaccine is on the horizon for preventing this medical catastrophe.